Literature DB >> 14733332

Tissue factor pathway inhibitor in thrombosis and beyond.

Shaker A Mousa1, Jawed Fareed, Omer Iqbal, Brigitte Kaiser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14733332     DOI： 10.1385/1-59259-658-4:133

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN： 1543-1894


× No keyword cloud information.
  3 in total

Review 1.  Pleiotropic effects of heparins: does anticoagulant treatment increase survival in cancer patients?

Authors:  I García-Escobar; C Beato-Zambrano; J Muñoz Langa; E Brozos Vázquez; B Obispo Portero; D Gutiérrez-Abad; A J Muñoz Martín
Journal:  Clin Transl Oncol       Date:  2018-02-22       Impact factor: 3.405

2.  Intensive-Dose Tinzaparin in Hospitalized COVID-19 Patients: The INTERACT Study.

Authors:  Karolina Akinosoglou; Christos Savopoulos; Abraham Pouliakis; Charalampos Triantafyllidis; Eleftherios Markatis; Foteini Golemi; Angelos Liontos; Charikleia Vadala; Ilias C Papanikolaou; Vasiliki Dimakopoulou; Panagiotis Xarras; Katerina Varela; Georgia Kaiafa; Athanasios Mitsianis; Anastasia Chatzistamati; Efthalia Randou; Spyridon Savvanis; Maria Pavlaki; Georgios Efraimidis; Vasileios Samaras; Dimitrios Papazoglou; Alexandra Konstantinidou; Periklis Panagopoulos; Haralampos Milionis
Journal:  Viruses       Date:  2022-04-07       Impact factor: 5.818

3.  Sepsis-induced thrombus formation and cell-specific HIFs.

Authors:  Colin E Evans; Addie B Spier; You-Yang Zhao
Journal:  Thromb Res       Date:  2018-08-31       Impact factor: 3.944
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.